. .
Clinical Stem 1
Non-smoking female with a new right upper lobe lung mass and three PET-positive mediastinal lymph nodes
Learning Outcome

At the conclusion of the 1st Clinical Stem webcast, viewers will be able to:
  1. Describe mediastinal staging and EBUS-guided nodal-sampling strategies.
  2. Describe the rationale for downstream molecular analysis of small tissue specimens.
  3. Describe ways to assure specimen adequacy for diagnosis and molecular testing.
  4. Describe indications for repeat biopsy and molecular analysis in case of disease progression.
  5. Describe how molecular analysis of adequate specimens helps determine prognosis and potential response or resistance to therapy.